Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study

Study question How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy? Methods In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were recruited from 30 UK allergy centres and immunised with LAIV...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ
Auteurs principaux: Turner, Paul J, Southern, Jo, Andrews, Nick J, Miller, Elizabeth, Erlewyn-Lajeunesse, Michel
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group Ltd. 2015
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673102/
https://ncbi.nlm.nih.gov/pubmed/26645895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.h6291
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires